Skin Cancer

BCC Patient Case Impressions
September 30, 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

Patient Case: 49-Year-Old Caucasian Woman With Neglected Large BCC
September 30, 2022

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

Future of BCC
September 30, 2022

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Immune Checkpoint Inhibitors Utilized in BCC
September 23, 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, discuss the impact of immune checkpoint inhibitors used in BCC.

BCC Treatment Landscape
September 23, 2022

Experts in dermatology discuss the treatment landscape for BCC.

Role of Precision Medicine in the Management of Melanoma
September 20, 2022

Precision medicine may help improve the diagnosis and management of melanoma.

Adjuvant Treatment With Nivolumab Shows Positive Results in Phase 3 Trial
September 16, 2022

Bristol Myers Squibb’s nivolumab shows potential for treatment in earlier stages of melanoma.

Best Practices for Preventing Advanced BCC and the Importance of Multidisciplinary Teams
September 16, 2022

Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.

Overview and Burden of BCC
September 16, 2022

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.

Skin Cancer Education and Prevention in Skin of Color Patients
September 10, 2022

At a poster session at the Skin of Color Update meeting in New York City, investigators looked at skin cancer education and prevention among patients with skin of color.